Are Investors Unfairly Punishing Sangamo Therapeutics Inc. (NASDAQ:SGMO)?
Sangamo Therapeutics Inc. (NASDAQ:SGMO) Relative Strength Index (RSI) is 52.36, with weekly volatility at 3.76% and ATR at 0.44. The SGMO stock’s 52-week price range
Sangamo Therapeutics Inc. (NASDAQ:SGMO) Relative Strength Index (RSI) is 52.36, with weekly volatility at 3.76% and ATR at 0.44. The SGMO stock’s 52-week price range
Sangamo Therapeutics Inc. (NASDAQ:SGMO) previous close was $11.75 while the outstanding shares total 143.11M. The firm has a beta of 1.71. SGMO’s shares traded lower
Sangamo Therapeutics Inc. (NASDAQ:SGMO) previous close was $11.56 while the outstanding shares total 143.11M. The firm has a beta of 1.71. SGMO’s shares traded lower
Sangamo Therapeutics Inc. (NASDAQ:SGMO) Relative Strength Index (RSI) is 46.64, with weekly volatility at 3.92% and ATR at 0.51. The SGMO stock’s 52-week price range
Sangamo Therapeutics Inc. (NASDAQ:SGMO) Relative Strength Index (RSI) is 46.74, with weekly volatility at 3.97% and ATR at 0.50. The SGMO stock’s 52-week price range
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne